IKT - Inhibikase Therapeutics, Inc.
2.16
0.200 9.259%
Share volume: 111,988
Last Updated: 04-23-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$1.96
0.20
0.10%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-15-2023 | 08-14-2023 | 11-14-2023 | 03-27-2024 | 05-15-2024 | 08-14-2024 | 11-14-2024 | 03-27-2025 | |
| Cash flow financing | 8.579 M | -35.986 K | 70.000 | -138.104 K | 366.999 K | 3.244 M | 181.954 K | 99.684 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | -30.608 K | 0.000 | 0.000 | 0.000 | |
| Cash flow | -5.972 M | -4.565 M | -4.105 M | -3.442 M | -6.812 M | 733.109 K | -2.173 M | 55.577 M | |
| Net income | -4.478 M | -5.778 M | -4.595 M | -4.178 M | -4.650 M | -4.960 M | -5.778 M | -12.133 M | |
| Depreciation | 5.043 K | 159.204 K | 6.583 K | 6.568 K | 6.568 K | 6.569 K | 6.568 K | 6.567 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 64.521 K | 79.604 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -5.839 M | 2.550 M | 17.061 M | -2.116 M | -3.312 M | 2.543 M | 2.526 M | -38.762 M | |
| Net Borrowings | -27.239 M | -21.606 M | -17.281 M | -13.589 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | -14.238 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 25.718 M | 20.935 M | 16.832 M | 13.252 M | -6.812 M | 733.109 K | -2.173 M | 55.577 M |
